WU and KI polyomaviruses in respiratory, blood and urine samples from renal transplant patients

Eszter Csoma, Beáta Mészáros, László Asztalos, L. Gergely

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Background: It is suggested that immunosuppression due to transplantation might be a risk for human polyomavirus KI (KIPyV) and WU (WUPyV) infection. Most of the publications report data about stem cell transplant patients, little is known about these virus infections in renal transplant patients. Objectives: To study the presence of KIPyV and WUPyV in upper respiratory, plasma and urine samples from renal transplant patients. To analyse clinical and personal data. Study design: 532 respiratory, 503 plasma and 464 urine samples were collected from 77 renal transplant patients. KIPyV and WUPyV were detected by nested and quantitative real-time PCR. Patient and clinical data from medical records were analyzed. Results: KIPyV was detected in respiratory, plasma and urine samples from 14.3%, 3.9% and 4.1% of renal transplant patients. WUPyV was found in respiratory and plasma specimens from 9.1% and 5.3% of the patients. Significant association was revealed between the detection of KIPyV and WUPyV and the time of samples collection and the age of the patients. KIPyV was presented in respiratory and plasma sample at the same time. KIPyV was detected in plasma samples from two patients and in urine samples of three other patients providing also KIPyV positive respiratory samples at the same time. No clinical consequences of KIPyV or WUPyV infection were found. Conclusion: Although no clinical consequences of KIPyV and WUPyV infections were found in renal transplant patients, it is suggested that renal transplantation might result in higher susceptibility or reactivation of these infection.

Original languageEnglish
Pages (from-to)28-33
Number of pages6
JournalJournal of Clinical Virology
Volume64
DOIs
Publication statusPublished - Mar 1 2015

Fingerprint

Polyomavirus
Urine
Transplants
Kidney
Infection
Virus Diseases
Kidney Transplantation
Immunosuppression
Medical Records
Publications
Real-Time Polymerase Chain Reaction
Stem Cells
Transplantation

Keywords

  • Human polyomaviruses
  • Immunocompromised patients
  • KIPyV
  • Renal transplanta
  • WUPyV

ASJC Scopus subject areas

  • Virology
  • Infectious Diseases

Cite this

WU and KI polyomaviruses in respiratory, blood and urine samples from renal transplant patients. / Csoma, Eszter; Mészáros, Beáta; Asztalos, László; Gergely, L.

In: Journal of Clinical Virology, Vol. 64, 01.03.2015, p. 28-33.

Research output: Contribution to journalArticle

Csoma, Eszter ; Mészáros, Beáta ; Asztalos, László ; Gergely, L. / WU and KI polyomaviruses in respiratory, blood and urine samples from renal transplant patients. In: Journal of Clinical Virology. 2015 ; Vol. 64. pp. 28-33.
@article{18c76591bd3147019533d6407cb0d0f3,
title = "WU and KI polyomaviruses in respiratory, blood and urine samples from renal transplant patients",
abstract = "Background: It is suggested that immunosuppression due to transplantation might be a risk for human polyomavirus KI (KIPyV) and WU (WUPyV) infection. Most of the publications report data about stem cell transplant patients, little is known about these virus infections in renal transplant patients. Objectives: To study the presence of KIPyV and WUPyV in upper respiratory, plasma and urine samples from renal transplant patients. To analyse clinical and personal data. Study design: 532 respiratory, 503 plasma and 464 urine samples were collected from 77 renal transplant patients. KIPyV and WUPyV were detected by nested and quantitative real-time PCR. Patient and clinical data from medical records were analyzed. Results: KIPyV was detected in respiratory, plasma and urine samples from 14.3{\%}, 3.9{\%} and 4.1{\%} of renal transplant patients. WUPyV was found in respiratory and plasma specimens from 9.1{\%} and 5.3{\%} of the patients. Significant association was revealed between the detection of KIPyV and WUPyV and the time of samples collection and the age of the patients. KIPyV was presented in respiratory and plasma sample at the same time. KIPyV was detected in plasma samples from two patients and in urine samples of three other patients providing also KIPyV positive respiratory samples at the same time. No clinical consequences of KIPyV or WUPyV infection were found. Conclusion: Although no clinical consequences of KIPyV and WUPyV infections were found in renal transplant patients, it is suggested that renal transplantation might result in higher susceptibility or reactivation of these infection.",
keywords = "Human polyomaviruses, Immunocompromised patients, KIPyV, Renal transplanta, WUPyV",
author = "Eszter Csoma and Be{\'a}ta M{\'e}sz{\'a}ros and L{\'a}szl{\'o} Asztalos and L. Gergely",
year = "2015",
month = "3",
day = "1",
doi = "10.1016/j.jcv.2014.12.020",
language = "English",
volume = "64",
pages = "28--33",
journal = "Journal of Clinical Virology",
issn = "1386-6532",
publisher = "Elsevier",

}

TY - JOUR

T1 - WU and KI polyomaviruses in respiratory, blood and urine samples from renal transplant patients

AU - Csoma, Eszter

AU - Mészáros, Beáta

AU - Asztalos, László

AU - Gergely, L.

PY - 2015/3/1

Y1 - 2015/3/1

N2 - Background: It is suggested that immunosuppression due to transplantation might be a risk for human polyomavirus KI (KIPyV) and WU (WUPyV) infection. Most of the publications report data about stem cell transplant patients, little is known about these virus infections in renal transplant patients. Objectives: To study the presence of KIPyV and WUPyV in upper respiratory, plasma and urine samples from renal transplant patients. To analyse clinical and personal data. Study design: 532 respiratory, 503 plasma and 464 urine samples were collected from 77 renal transplant patients. KIPyV and WUPyV were detected by nested and quantitative real-time PCR. Patient and clinical data from medical records were analyzed. Results: KIPyV was detected in respiratory, plasma and urine samples from 14.3%, 3.9% and 4.1% of renal transplant patients. WUPyV was found in respiratory and plasma specimens from 9.1% and 5.3% of the patients. Significant association was revealed between the detection of KIPyV and WUPyV and the time of samples collection and the age of the patients. KIPyV was presented in respiratory and plasma sample at the same time. KIPyV was detected in plasma samples from two patients and in urine samples of three other patients providing also KIPyV positive respiratory samples at the same time. No clinical consequences of KIPyV or WUPyV infection were found. Conclusion: Although no clinical consequences of KIPyV and WUPyV infections were found in renal transplant patients, it is suggested that renal transplantation might result in higher susceptibility or reactivation of these infection.

AB - Background: It is suggested that immunosuppression due to transplantation might be a risk for human polyomavirus KI (KIPyV) and WU (WUPyV) infection. Most of the publications report data about stem cell transplant patients, little is known about these virus infections in renal transplant patients. Objectives: To study the presence of KIPyV and WUPyV in upper respiratory, plasma and urine samples from renal transplant patients. To analyse clinical and personal data. Study design: 532 respiratory, 503 plasma and 464 urine samples were collected from 77 renal transplant patients. KIPyV and WUPyV were detected by nested and quantitative real-time PCR. Patient and clinical data from medical records were analyzed. Results: KIPyV was detected in respiratory, plasma and urine samples from 14.3%, 3.9% and 4.1% of renal transplant patients. WUPyV was found in respiratory and plasma specimens from 9.1% and 5.3% of the patients. Significant association was revealed between the detection of KIPyV and WUPyV and the time of samples collection and the age of the patients. KIPyV was presented in respiratory and plasma sample at the same time. KIPyV was detected in plasma samples from two patients and in urine samples of three other patients providing also KIPyV positive respiratory samples at the same time. No clinical consequences of KIPyV or WUPyV infection were found. Conclusion: Although no clinical consequences of KIPyV and WUPyV infections were found in renal transplant patients, it is suggested that renal transplantation might result in higher susceptibility or reactivation of these infection.

KW - Human polyomaviruses

KW - Immunocompromised patients

KW - KIPyV

KW - Renal transplanta

KW - WUPyV

UR - http://www.scopus.com/inward/record.url?scp=84923321931&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84923321931&partnerID=8YFLogxK

U2 - 10.1016/j.jcv.2014.12.020

DO - 10.1016/j.jcv.2014.12.020

M3 - Article

C2 - 25728075

AN - SCOPUS:84923321931

VL - 64

SP - 28

EP - 33

JO - Journal of Clinical Virology

JF - Journal of Clinical Virology

SN - 1386-6532

ER -